News about us
Recent articles that mention MVI
(Click on headline to read the full story.)
Africa: New push on malaria
November 22, 2013 – Malaria researchers believe that better coordination and new technologies, such as the use of vaccines and sophisticated disease mapping, can inject new life into the ambitious goal of eradicating the deadly illness.
Technology roadmap resets targets on malaria vaccines
November 14, 2013 – More efficacious malaria vaccines and those that could eliminate the disease in different settings should be available by 2030, according to the 2013 Malaria Vaccine Technology Roadmap, announced today in The Lancet.
Malaria vaccine could be ready by 2015
October 22, 2013 – The world’s first malaria vaccine could be available within the next 18 months, marking a major advance in efforts to eradicate a disease that kills more than half a million people, many of them children, every year.
Hope for a malaria vaccine
October 13, 2013 – The most ambitious clinical trial of a malaria vaccine has shown some effectiveness in children over an 18-month period. While its efficacy is modest, it is nonetheless a significant advance in the long struggle to control a disease that kills some 600,000 people a year, mostly children under the age of 5.
The New York Times
The long war
October 12, 2013 – On October 8th researchers announced progress in developing a vaccine against malaria. GlaxoSmithKline (GSK), a British pharmaceutical firm, said it would seek regulatory approval next year for this vaccine, called RTS,S. GSK and its charitable partner, the PATH Malaria Vaccine Initiative, also revealed new data showing the vaccine’s effect in children. This is good news, but RTS,S will not vanquish malaria by itself.
A shot against malaria
October 11, 2013 – Even through a crackled cellular connection from Durban, South Africa, the optimism can be heard in Dr. David Kaslow’s mild-mannered voice. “It’s been a fairly long road. Twenty-plus years in development. There’s been a lot of twists and turns.”
The New Yorker
First malaria vaccine moves a step closer to approval
October 8, 2013 – A malaria vaccine studied in more than 15,000 African children has been found to reduce the number of cases of disease by 27 to 46 percent.
UK firm seeks to market world's first malaria vaccine
October 8, 2013 – British drug maker GlaxoSmithKline is seeking regulatory approval for the world's first malaria vaccine after trial data showed that it had cut the number of cases in African children.
Africa: Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study
October 7, 2013 – Durban, South Africa — Results from a large-scale Phase III trial, presented today in Durban at the Multilateral Initiative on Malaria Pan African Conference, show that the most clinically advanced malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 months after vaccination.
Hope of malaria vaccine by 2015 after successful trials
October 7, 2013 – A vaccine against malaria could be introduced in the world's worst-hit countries in 2015, after the latest trial of a treatment produced by Britain's biggest drug company reduced the number of cases of the disease experienced by babies.
A fresh start, back in Brazil, at 85
June 25, 2013 – Ruth and Victor Nussenzweig have reached a point in their careers when most scientist-couples probably would choose a well-deserved retirement. Based at New York University (NYU) in New York City, the Nussenzweigs, who are both 85—they have been married for 60 years—have already had long, successful, independent careers. While Ruth has focused on providing the basis for the development of a malaria vaccine, Victor concentrated on basic immunology, studying the structure and function of various immune components and the parasitology of malaria and Chagas disease.
Adding vaccines to intensify the assault on malaria
May 9, 2013 – At the turn of the last century, the call to action to bring to bear tools such as insecticide-treated bed nets, malaria rapid diagnostic tests and artemisinin-based combination therapies, was heard. Governments, foundations, non-profit groups, and the commercial sector mobilized to stem the tide against an ancient scourge—the result has been an estimated 274 million malaria cases and 1.1 million deaths averted between 2001 and 2010.
USAID Impact blog
Opinion pieces published in recognition of World Malaria Day
April 26, 2013 – Wednesday was World Malaria Day, observed annually on April 25. This year's theme was "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.
Africa: Malaria - the ongoing fight against an old, adaptive foe
April 25, 2013 – As the global public health community solemnly marks World Malaria Day, attention turns to the human toll enacted by this deadly disease and the measures needed to eradicate it.
Assessing private sector support of global health
April 15, 2013 – There is considerable excitement regarding the role that corporations and their foundations are playing in global health. PSI and other prominent global health organizations are expecting this trend to continue and are counting on the private sector, particularly large multinational companies, to implement innovative and scalable health programs, establish new partnerships, and provide much-needed funding to catalyze sustainable change.
Infectious diseases topic at Washington University conference
April 11, 2013 – Some of the world’s experts in infectious diseases will gather on Friday at the Washington University medical school to discuss the latest progress in fighting malaria, HIV/AIDS, tuberculosis and other challenging diseases.
St. Louis Post-Dispatch
The quest to end malaria deaths by 2015: The search for an effective malaria vaccine
February 19, 2013 – Malaria is a treatable and preventable disease. However, the disease continues to claim lives, especially of children under five years of age and pregnant women.
New plans to improve malaria vaccine
January 19, 2013 – Scientists have started a new project to enhance the malaria vaccine, giving fresh impetus to the fight against the killer disease.
The East African
Funding the future: Getting pharmaceuticals to tackle disease in Africa
January 17, 2013 – The RTS,S trial was not the success the public health community was hoping for—especially given that earlier trials showed 55% efficacy in children between 5 and 17 months. But it is still too early to give up on the vaccine, and more detailed results from the trial are set for release in 2014.
Think Africa Press
PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals partner to accelerate development of malaria vaccines and innovative delivery technologies
January 7, 2013 – The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
Philadelphia Business Journal
Search for new malaria vaccine begins
January 7, 2013 – A new project to advance malaria vaccine development and new vaccine delivery technologies has been launched.
The Guardian Nigeria
PATH's malaria team partners with Inovio on new vaccine approach
January 7, 2013 – Seattle-based PATH is partnering with Inovio Pharmaceuticals Inc. to work on the global health organization’s Malaria Vaccine Initiative.
Puget Sound Business Journal
Malaria vaccine trial: an interview with Professor Sir Brian Greenwood
December 14, 2012 – Interview conducted by April Cashin-Garbutt, BA Hons (Cantab)
Interview with Dr. David Kaslow
August 30, 2012 – Dr. Kaslow was announced as the new leader of PATH MVI on the first of March of this year. In this podcast interview, Dr. Kaslow discusses about the PATH MVI organization and its involvement in the development of the malaria vaccine RTS,S/AS01 as well as his vision for the future of his organization.
Malaria vaccination may begin in 2014, funding, innovation critical to success
July 16, 2012 – A malaria vaccine that could help protect young children and infants in malaria-endemic areas against infection and clinical disease caused by plasmodium falciparum, the most deadly species of the malaria parasite, may become available globally by the end of 2014.
The Guardian Nigeria
Are green vaccines appropriate for Africa?
June 11, 2012 – A blog post about plant-based vaccines, written by Ed Rybicki.
Building bridges in a new global health landscape
June 4, 2012 – Guest post by Steve Davis: Today I begin a new chapter in my life as president and CEO of the global health organization PATH. Why has this business and social entrepreneur, IP attorney, and human rights activist made this leap?
Seattle has big impact on global fight against malaria
April 25, 2012 – It's World Malaria Day, and Seattle research organizations and foundations are doing their part to spread awareness and invest in research.
Puget Sound Business Journal
Particle technology delivers medicines and vaccines
March 9, 2012 – When Joseph DeSimone met Bill Gates about 18 months ago at a conference in California, he knew he had about ten seconds to engage him. So he told him, right away, how his new company was using computer industry manufacturing techniques to develop innovative vaccines and medicines.
US News and World Report
Sharing data in the search for a malaria vaccine
March 8, 2012 – The search for a malaria vaccine has defied the widely held view that African scientists are not willing to share research details to support a breakthrough in finding a vaccine which is thought to be in its final stages.
Commentary: What I learned far away from public health school
March 6, 2012 – Commentary piece from Kayla Laserson, director of the Kenya Medical Research Institute/CDC Field Research Station.
India opens malaria vaccine center
March 6, 2012 – Two Seattle-based nonprofits have partnered with India's Gennova Biopharmaceuticals to help make a transmission-blocking vaccine a reality.
Areas with low malaria rates 'need mass vaccination'
January 25, 2012 – The most promising malaria vaccine candidate should be rolled out through mass vaccination campaigns—rather than the WHO's routine infant vaccinations—in parts of Africa with low malaria transmission, says a study.
Show 60: Excerpt – The Malaria Vaccine Initiative
January 17, 2012 – Kids These Days! producer Sarah Gonzales spoke with David Poland at PATH to learn about the RTS,S vaccine candidate's initial trial results in some some of Africa's youngest children.
Kids These Days!
The remarkable journey of the RTS,S vaccine
January 12, 2012 – It is no easy task following over 15,000 children across 11 sites, two in Ghana (Agogo and Kintampo) and the rest in Kenya, Mozambique, Tanzania, Malawi, Burkina Faso and Gabon in a Phase 3 RTS,S vaccine trials, described as the largest malarial clinical trials in Africa.
New vaccine could help end malaria
January 11, 2012 – The tropical disease kills more people annually than cancer, but researchers think they can win the fight.
Promising in trial, malaria vaccine inches toward deployment
January 2012 – Interim results from a large clinical trial show that RTS, S/AS01vaccine cut the incidence of malaria by half among children aged 5 to 17 months.